Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Hepato-Gastroenterology|November 21, 2012
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experienceUmut Kefeli, Suleyman Buyuberber, Murat Akyol, et al.JCO Precision Oncology|January 24, 2025
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 TrialSun Young Rha, Yanqiao Zhang, Anneli Elme, et al.Journal of Cancer Research and Clinical Oncology|February 13, 2013
Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)Umut Demirci, Gulnihal Tufan, Bilge Aktas, et al.Journal of Cancer Research and Clinical Oncology|December 3, 2013
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyOzge Gumusay, Ugur Coskun, Tülay Akman, et al.Clinical Colorectal Cancer|September 28, 2016
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative ResectionDincer Aydin, Mehmet Ali Sendur, Umut Kefeli, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 13, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRCMahmut Emre Yildirim, Nuri Karadurmuş, İlker Nihat Ökten, et al.Anti-Cancer Drugs|June 15, 2022
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group studyÖzlem Özdemir, Baha Zengel, Yaşar Yildiz, et al.Pageof 9